These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 32402780)

  • 1. Impact of Anticholinergic Burden on Cognitive Performance: A Cohort Study of Community-Dwelling Older Adults.
    Nishtala PS; Allore H; Han L; Jamieson HA; Hilmer SN; Chyou TY
    J Am Med Dir Assoc; 2020 Sep; 21(9):1357-1358.e3. PubMed ID: 32402780
    [No Abstract]   [Full Text] [Related]  

  • 2. Medication Profiles of Patients with Cognitive Impairment and High Anticholinergic Burden.
    Green AR; Reifler LM; Boyd CM; Weffald LA; Bayliss EA
    Drugs Aging; 2018 Mar; 35(3):223-232. PubMed ID: 29404965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticholinergic Burden and Cognition in Older Patients With Schizophrenia.
    Tsoutsoulas C; Mulsant BH; Kumar S; Ghazala Z; Voineskos AN; Menon M; Pollock BG; Rajji TK
    J Clin Psychiatry; 2017; 78(9):e1284-e1290. PubMed ID: 29188908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse Effects of Anticholinergic Drugs on Cognition and Mobility: Cutoff for Impairment in a Cross-Sectional Study in Young-Old and Old-Old Adults.
    Attoh-Mensah E; Loggia G; Schumann-Bard P; Morello R; Descatoire P; Marcelli C; Chavoix C
    Drugs Aging; 2020 Apr; 37(4):301-310. PubMed ID: 31930459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between using medications with anticholinergic properties and short-term cognitive decline among older men: A retrospective cohort study in Taiwan.
    Wu YH; Wang CJ; Hung CH; Chen LY; Lin MH; Wang PN; Chen LK
    Geriatr Gerontol Int; 2017 Apr; 17 Suppl 1():57-64. PubMed ID: 28436193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticholinergic Drug Use and Risk to Cognitive Performance in Older Adults with Questionable Cognitive Impairment: A Cross-Sectional Analysis.
    Swami S; Cohen RA; Kairalla JA; Manini TM
    Drugs Aging; 2016 Nov; 33(11):809-818. PubMed ID: 27638818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticholinergic Burden in Older Adults with Mild Cognitive Impairment.
    Green AR; Oh E; Hilson L; Tian J; Boyd CM
    J Am Geriatr Soc; 2016 Dec; 64(12):e313-e314. PubMed ID: 27879986
    [No Abstract]   [Full Text] [Related]  

  • 8. Association of Anticholinergic Burden with Cognitive Impairment and Health Care Utilization Among a Diverse Ambulatory Older Adult Population.
    Campbell NL; Perkins AJ; Bradt P; Perk S; Wielage RC; Boustani MA; Ng DB
    Pharmacotherapy; 2016 Nov; 36(11):1123-1131. PubMed ID: 27711982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug Burden Index and change in cognition over time in community-dwelling older men: the CHAMP study.
    Jamsen KM; Gnjidic D; Hilmer SN; Ilomäki J; Le Couteur DG; Blyth FM; Handelsman DJ; Naganathan V; Waite LM; Cumming RG; Bell JS
    Ann Med; 2017 Mar; 49(2):157-164. PubMed ID: 27763767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term anticholinergic, benzodiazepine and Z-drug use in community-dwelling older adults: What is the impact on cognitive and neuropsychological performance?
    Dyer AH; Laird E; Hoey L; Hughes CF; McNulty H; Ward M; Strain JJ; Molloy AM; Cunningham C; McCarroll K
    Int J Geriatr Psychiatry; 2021 Nov; 36(11):1767-1777. PubMed ID: 34227695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticholinergic drug usage and cognitive impairment: findings from three large European cohort studies.
    Hu M; Hughes T
    J Neurol; 2019 Jul; 266(7):1816-1818. PubMed ID: 31197512
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of Anticholinergic Burden Measured with Three Different Anticholinergic Risk Scales and Association with Cognitive and Physical Functions in Older Adults.
    Soysal T; Akın S; Durmuş NŞ; Gökçekuyu BM; Özer FF; Zararsız GE
    Arch Gerontol Geriatr; 2021; 96():104451. PubMed ID: 34130072
    [No Abstract]   [Full Text] [Related]  

  • 13. Association of Anticholinergic Drug Burden with Cognitive and Functional Decline Over Time in Older Inpatients: Results from the CRIME Project.
    Brombo G; Bianchi L; Maietti E; Malacarne F; Corsonello A; Cherubini A; Ruggiero C; Onder G; Volpato S
    Drugs Aging; 2018 Oct; 35(10):917-924. PubMed ID: 30191516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticholinergics Influence Transition from Normal Cognition to Mild Cognitive Impairment in Older Adults in Primary Care.
    Campbell NL; Lane KA; Gao S; Boustani MA; Unverzagt F
    Pharmacotherapy; 2018 May; 38(5):511-519. PubMed ID: 29600808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticholinergic Medications and Cognitive Function in Late Midlife.
    Limback-Stokin MM; Krell-Roesch J; Roesler K; Hansen A; Stonnington CM; Temkit M; Caselli RJ; Geda YE
    Alzheimer Dis Assoc Disord; 2018; 32(3):262-264. PubMed ID: 29481373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticholinergic effect on cognition (AEC) of drugs commonly used in older people.
    Bishara D; Harwood D; Sauer J; Taylor DM
    Int J Geriatr Psychiatry; 2017 Jun; 32(6):650-656. PubMed ID: 27280553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between Anticholinergic Drug Use and Health-Related Quality of Life in Community-Dwelling Older Adults.
    Cossette B; Bagna M; Sene M; Sirois C; Lefebvre GP; Germain O; Morais JA; Gaudreau P; Payette H
    Drugs Aging; 2017 Oct; 34(10):785-792. PubMed ID: 28801707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between anticholinergic (atropinic) drug exposure and cognitive function in longitudinal studies among individuals over 50 years old: a systematic review.
    Andre L; Gallini A; Montastruc F; Montastruc JL; Piau A; Lapeyre-Mestre M; Gardette V
    Eur J Clin Pharmacol; 2019 Dec; 75(12):1631-1644. PubMed ID: 31468067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact of Medication Anticholinergic Burden on Cognitive Performance in People With Schizophrenia.
    Ang MS; Abdul Rashid NA; Lam M; Rapisarda A; Kraus M; Keefe RSE; Lee J
    J Clin Psychopharmacol; 2017 Dec; 37(6):651-656. PubMed ID: 29016375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of anticholinergic burden on cognitive and daily living functions in patients with schizophrenia.
    Kim SJ; Jung D; Shim JC; Moon JJ; Jeon DW; Kim YN; Seo YS; Jung SS; Seo BJ; Kim JE
    Asian J Psychiatr; 2019 Dec; 46():111-117. PubMed ID: 31654923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.